Tommy Moya-Alfaro
610 University Ave. OPG Rm 6-222
Toronto, ON M5G2M9, Canada
Toronto, ON M5G2M9, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.
Journal: JCO oncology practice
Published: June 29, 2026
Prior Malignancy History and Risk of Second Malignancies After Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: March 21, 2026
Ferritin as a Pre-Transplant Biomarker for Post-Transplant Outcomes in Allogeneic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide.
Journal: Transplantation and cellular therapy
Published: January 14, 2026
HCT Frailty Scale (HCT-FS) for assessing frailty in adult candidates for allogeneic haematopoietic cell transplantation: an international prospective, observational cohort study.
Journal: EClinicalMedicine
Published: August 05, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival.
Journal: Annals of hematology
Published: July 14, 2025
A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantation.
Journal: British journal of haematology
Published: June 10, 2025
Endothelial activation and stress index (EASIX) as a biomarker to predict ruxolitinib failure for steroid-refractory acute graft-versus-host disease treatment.
Journal: British journal of haematology
Published: June 07, 2025
Impact of graft-versus-host disease prophylaxis on second primary malignancies after allogeneic haematopoietic stem cell transplantation.
Journal: British journal of haematology
Published: May 21, 2025
Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Leukemia.
Journal: Transplantation and cellular therapy
Published: May 20, 2025
Conditioning Regimens for Second Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Graft Failure.
Journal: Transplantation and cellular therapy
Published: April 25, 2025
Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation.
Journal: Cancers
Published: January 23, 2025
Last Updated: 09/26/2026